Document is current
Any future updates will be listed below
-
Authors
Faerman, Afik http://orcid.org/0000-0001-7140-8204
Bishop, James H.
Stimpson, Katy H.
Phillips, Angela
Gülser, Merve http://orcid.org/0000-0003-3659-1853
Amin, Heer
Nejad, Romina
DeSouza, Danielle D.
Geoly, Andrew D.
Kallioniemi, Elisa http://orcid.org/0000-0001-6706-2837
Jo, Booil
Williams, Nolan R. http://orcid.org/0000-0003-4368-3203
Spiegel, David http://orcid.org/0000-0002-9476-9173
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Center for Complementary and Integrative Health (R33AT009305, R33AT009305, R33AT009305)
- License Information
-
More Information
Article History
Received: 28 February 2023
Accepted: 14 November 2023
First Online: 4 January 2024
Competing interests
: N.R.W. is a named inventor on Stanford-owned intellectual property relating to accelerated TMS pulse pattern sequences and neuroimaging-based TMS targeting; he has served on scientific advisory boards for Otsuka, NeuraWell, Magnus Medical and Nooma as a paid advisor; he also has equity/stock options in Magnus Medical, NeuraWell and Nooma. There were no financial conflicts during the conduct of the trial or analysis of the data in this Article. D.S. is a co-founder of Reveri Health, Inc., an interactive hypnosis app (not utilized in the current study). A.F. is a consultant for Reveri Health, Inc. The other authors declare no competing interests.
